Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Catalio Capital Management, LP files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Evan Lockwood Rachlin - $11.50M in IAM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Catalio Capital Management, LP?
Catalio Capital Management, LP is an investment firm, tracked as 10% Owner of Iambic Therapeutics, Inc. (IAM). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Catalio Capital Management, LP submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
